Index by author

October 01, 2015; Volume 82,Issue 10

  1. Mccabe, Marshall Edward

    1. A 56-year-old with diarrhea and weakness
      Marshall Edward McCabe, DO and Areeba Y. Kara, MD, MS, FACP
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 671-676; DOI: https://doi.org/10.3949/ccjm.82a.14124

      The patient has unintentionally lost 137 lb over the past year. What is the cause?

  2. Mehta, Atul C.

    1. Lady Windermere syndrome: Mycobacterium of sophistication
      Christopher Donatelli, MD and Atul C. Mehta, MD, FACP, FCCP
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 641-643; DOI: https://doi.org/10.3949/ccjm.82a.14100

      The typical patient is a thin, well-mannered elderly woman who voluntarily suppresses her cough out of politeness.

  3. Messinger-rapport, Barbara J.

    1. What can we offer patients with mild cognitive impairment?
      Tara Horr, MD, Jagan A. Pillai, MBBS, PhD and Barbara J. Messinger-Rapport, MD, PhD
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 650-652; DOI: https://doi.org/10.3949/ccjm.82a.14130

      Physicians can promote healthy nutrition, physical activity, socialization, and mental activity, but no drug is approved for it.

  4. Montague, Drogo K.

    1. Genitourinary manifestations of sickle cell disease
      Surafel Gebreselassie, MD, Matthew N. Simmons, MD, PhD and Drogo K. Montague, MD
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 679-683; DOI: https://doi.org/10.3949/ccjm.82a.14029

      Sickling can lead to nephropathy, priapism, papillary necrosis, and renal medullary carcinoma.

  5. Nielsen, Craig

    1. In Reply: Starting insulin therapy (August 2015)
      Andre Brateanu, MD, FACP, Giavanna Russo-Alvarez, PharmD, BCACP and Craig Nielsen, MD, FACP
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 638-639; DOI: https://doi.org/10.3949/ccjm.82c.10002

      Readers comment on resuming anticoagulation after hemorrhage (April 2015) and on starting insulin therapy in patients with type 2 diabetes (August 2015).

  6. Pillai, Jagan A.

    1. What can we offer patients with mild cognitive impairment?
      Tara Horr, MD, Jagan A. Pillai, MBBS, PhD and Barbara J. Messinger-Rapport, MD, PhD
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 650-652; DOI: https://doi.org/10.3949/ccjm.82a.14130

      Physicians can promote healthy nutrition, physical activity, socialization, and mental activity, but no drug is approved for it.

  7. Rothberg, Michael B.

    1. Why do clinicians continue to order ‘routine preoperative tests’ despite the evidence?
      Andrei Brateanu, MD and Michael B. Rothberg, MD, MPH
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 667-670; DOI: https://doi.org/10.3949/ccjm.82a.15118

      The authors propose several reasons and possible solutions.

  8. Russo-alvarez, Giavanna

    1. In Reply: Starting insulin therapy (August 2015)
      Andre Brateanu, MD, FACP, Giavanna Russo-Alvarez, PharmD, BCACP and Craig Nielsen, MD, FACP
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 638-639; DOI: https://doi.org/10.3949/ccjm.82c.10002

      Readers comment on resuming anticoagulation after hemorrhage (April 2015) and on starting insulin therapy in patients with type 2 diabetes (August 2015).

  9. Sabe, Marwa A.

    1. A new class of drugs for systolic heart failure: The PARADIGM-HF study
      A new class of drugs for systolic heart failure: The PARADIGM-HF study
      Marwa A. Sabe, MD, MPH, Miriam S. Jacob, MD and David O. Taylor, MD
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 693-701; DOI: https://doi.org/10.3949/ccjm.82a.14163

      Valsartan-sacubitril is the first new drug in over a decade to decrease death rates in patients with systolic heart failure.

  10. Simmons, Matthew N.

    1. Genitourinary manifestations of sickle cell disease
      Surafel Gebreselassie, MD, Matthew N. Simmons, MD, PhD and Drogo K. Montague, MD
      Cleveland Clinic Journal of Medicine October 2015, 82 (10) 679-683; DOI: https://doi.org/10.3949/ccjm.82a.14029

      Sickling can lead to nephropathy, priapism, papillary necrosis, and renal medullary carcinoma.

« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue